Scribe Therapeutics

Our mission is to cure disease by writing in the code of life. We are pioneering tissue-targeted non-viral delivery technology to make genomic alterations where they are needed. The first of its kind, Gene Writing is a versatile technology platform that can permanently make small and large alterations to the human genome.

We are now ready to partner in the therapeutics arena. We have just achieved our goal of creating the world’s best working genome editing platform. Founded 2012, we have since accumulated some of the most valuable IP in the field. TargetGene’s tightly knit teamis deeply passionate about bringing cures to patients.

We are scientific pioneers with unlimited potential to cure genetic disease. We are scientists and leaders on a shared mission to make innovative, curative therapies available to patients with devastating genetic diseases. We are guided by curiosity, rigor, and integrity. We are pioneers with unlimited potential to cure genetic disease. Our highly innovative, next-generation platform allows us to target any genomic sequence and develop life-changing therapies for the most challenging genetic disorders. They were developed from a proprietary collection of non-pathogenic organisms and offer gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. Life Edit Therapeutics has joined ElevateBio’s portfolio of therapeutic, technology, and manufacturing companies and reimagined our identity. Our brand is an expression of our values, mission, and commitment to paving the way to faster, safer, more innovative gene editing therapeutics that treat diseases once thought to be incurable.

We are committed to tackling a critical challenge in cell and gene therapy: delivering the gene-editing complex effectively. We are dedicated to bringing our technology to patients and delivering on the promise to improve patient care. We are always looking for those who are ready to share their vision and talent. Our team is built on a foundation of innovation and technology. Be prepared to go above and beyond expectations to deliver the best outcomes. We leverage nature’s own mechanisms for cellular uptake to ensure efficient and safe therapeutic delivery. The mission of NTrans Technologies is to become the leading non-viral delivery platform in cell and gene therapy. We have developed a game-changing, modular delivery platform, designed for easy integration with the therapeutic development processes of our strategic partners.

We are developing next-generation gene editing medicines to cure rare genetic diseases at their roots by correcting inborn genetic errors directly in patients’ cells. Founded in 2018 based on the scientific discoveries of Anna Cereseto’s laboratory.

Pioneering RNA editing to deliver the future of medicine.